193 related articles for article (PubMed ID: 36071046)
21. A molecular prognostic model predicts esophageal squamous cell carcinoma prognosis.
Cao HH; Zheng CP; Wang SH; Wu JY; Shen JH; Xu XE; Fu JH; Wu ZY; Li EM; Xu LY
PLoS One; 2014; 9(8):e106007. PubMed ID: 25153136
[TBL] [Abstract][Full Text] [Related]
22. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value and functional bioinformatic analysis of spindle- and kinetochore-associated protein 1 in stage IIA esophageal squamous cell carcinoma.
Hu D; Zhang M; Peng Z
J Cancer Res Ther; 2020 Sep; 16(5):1157-1164. PubMed ID: 33004764
[TBL] [Abstract][Full Text] [Related]
24. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Zhang X; He C; He C; Chen B; Liu Y; Kong M; Wang C; Lin L; Dong Y; Sheng H
Pathol Res Pract; 2013 Aug; 209(8):510-5. PubMed ID: 23880164
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
Li X; Xiao X; Chang R; Zhang C
J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
[TBL] [Abstract][Full Text] [Related]
26. Integrated transcriptomics explored the cancer-promoting genes CDKN3 in esophageal squamous cell cancer.
Wang W; Liao K; Guo HC; Zhou S; Yu R; Liu Y; Pan Y; Pu J
J Cardiothorac Surg; 2021 May; 16(1):148. PubMed ID: 34044866
[TBL] [Abstract][Full Text] [Related]
27. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
[TBL] [Abstract][Full Text] [Related]
28. UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma.
Wang X; Liu Y; Leng X; Cao K; Sun W; Zhu J; Ma J
Pathol Oncol Res; 2021; 27():632531. PubMed ID: 34257599
[No Abstract] [Full Text] [Related]
29. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
30. Downregulation of 14-3-3σ correlates with multistage carcinogenesis and poor prognosis of esophageal squamous cell carcinoma.
Qi YJ; Wang M; Liu RM; Wei H; Chao WX; Zhang T; Lou Q; Li XM; Ma J; Zhu H; Yang ZH; Liu HQ; Ma YF
PLoS One; 2014; 9(4):e95386. PubMed ID: 24743601
[TBL] [Abstract][Full Text] [Related]
31. Frequency, characterization, and prognostic analysis of PIK3CA gene mutations in Chinese esophageal squamous cell carcinoma.
Hou J; Jiang D; Zhang J; Gavine PR; Xu S; Liu Y; Xu C; Huang J; Tan Y; Wang H; Lu Y; Zheng L; Hou Y; Tan L
Hum Pathol; 2014 Feb; 45(2):352-8. PubMed ID: 24360885
[TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
[TBL] [Abstract][Full Text] [Related]
33. Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma.
Shi X; Li Y; Pan S; Liu X; Ke Y; Guo W; Wang Y; Ruan Q; Zhang X; Ma H
Sci Rep; 2022 Feb; 12(1):1960. PubMed ID: 35121801
[TBL] [Abstract][Full Text] [Related]
34. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of p62 and/or NFE2L2 induced autophagy impaires esophageal squamous cell cancer metastasis by reversing EMT.
Chen X; Yu L; Zhou J; Ren J; Wang S; Tan Y; Ding Y
Gene; 2023 Mar; 858():147194. PubMed ID: 36641074
[TBL] [Abstract][Full Text] [Related]
37. Integrative genome-wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma.
Takemoto A; Tanimoto K; Mori S; Inoue J; Fujiwara N; Noda T; Inazawa J
Cancer Sci; 2021 Oct; 112(10):4377-4392. PubMed ID: 34263978
[TBL] [Abstract][Full Text] [Related]
38. Integrative ontology and pathway-based approach identifies distinct molecular signatures in transcriptomes of esophageal squamous cell carcinoma.
Udhaya Kumar S; Balasundaram A; Anu Preethi V; Chatterjee S; Kameshwari Gollakota GV; Kashyap MK; George Priya Doss C; Zayed H
Adv Protein Chem Struct Biol; 2022; 131():177-206. PubMed ID: 35871890
[TBL] [Abstract][Full Text] [Related]
39. PIK3CA promotes proliferation and motility but is unassociated with lymph node metastasis or prognosis in esophageal squamous cell carcinoma.
Zheng S; Yang C; Lu M; Liu Q; Liu T; Dai F; Gao X; Sheyhidin I; Lu X
Hum Pathol; 2016 Jul; 53():121-9. PubMed ID: 27001433
[TBL] [Abstract][Full Text] [Related]
40. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
